.ao. all1pektopa Ha V1V1T - 6AH

Size: px
Start display at page:

Download ".ao. all1pektopa Ha V1V1T - 6AH"

Transcription

1 iJ1Q.ao all1pektopa Ha V1V1T - 6AH HHcmnrr no H" OPM. TEXHOnOfHU SAJ-f C0::l>MH., ( ax. N!!.! ".<f..20rl.(!.r. YaaJKaeMU 2ocnoouH,[lupeKmop, npvino>keho BVI Vl3npaL.LtaM npenvlc~vl3ene4ehvle OT npotokona Ha 28-TO 3ace,QaHVle Ha V-TO OC Ha bah, npoee,qeho Ha r. Ha Toea 3ace,QaHVle ce pewvl : npeo6pa3yea IIlHcTVlTYTa no napanenha o6pa6otka Ha VlHcpopMaL\VlflTa,,1I1HcTVlTYTa no VlHcpopMaL\VlOHHVI TeXHonorVlVl VI IIlHcTVlTYTa no KOMnlOTbpHVI VI KOMYHVlKaL\VlOHHVI CVlCTeMVI, 4pe3 cnvleahe VI Cb3,Qaea, KaTO TexeH YHVleepcaneH npaeonpvlemhvlk IIlHCTVlTYT no VlHcpopMaL\VlOHHVI VI KOMYHVI'KaqVloHHVI TeXHonorVlVl. npenvlc-vl3ene4ehvleto L.Lte BVI nocny>kvi 3a enviceaheto Ha Heo6xo,QVlMVlTe npomehvi e pervlctpal\vlvlte, noc04ehvi B nvicmo Ha npe,qce,qatenfl Ha bah C Vl3X. NQ OT r. VI nvicmo Ha rnaehvlfi HaY4eH cekpetap Ha bah C Vl3X. NQ T r. (e Toea nvicmo,qatata r.,qa ce C4V1Ta 21 IOHVI 2010 r., a,qatata 01 IOHVI 2010 r.,qa ce C4V1Ta 01 IOnVi 2010 r.) PeweHVleTO 3a npomehvlte envl3a e cvlna OT 1 IOnVi 2010 r., CbrnaCHO pewehvle Ha OC Ha bah, e3eto Ha 36-TO 3ace,QaHVle Ha OC Ha :bah OT r. npvlno>kehvle: L 6p. npenvlc-vl3bne4ehvle.

2 5bnrAPCKA A KAA E M V1~ HA HAYK V1TE npenmc-m3bne~ehme 06~O Cb 6PAH ~E Ha 31 MapT 2010 r. OT aca ce npobeae ABaAeceT M OCMOTO 3aceAaHL.1e Ha netoto 06Ll..1o cb6pahl.1e Ha 6bnrapcKaTa akaaeml.1f1 Ha HaYKL.1Te, CBL.1KaHO Ha OCHOBaHL.1e 3 OT npexoahl.1te L.1 3aKnI04L.1TenHVlTe pa3nopea6v1 L.1 8 L.13nbnHeHL.1e Ha 4n. 5 OT 3aKoHa 3a bah. )1;HeBeH pe.z::.: 1. 06C'D)l()J,aHe H rrphemahe Ha MeTo.n;wlecKH YKa3aHIUI H ATecTaQHoHHa KapTa 3a atecthpahe Ha yqehh B camoctoktejihhte HaYQHH 3BeHa Ha EAH. 2. OOC'b~aHe H r JlacYBaHe Ha noctohhhh HayqHH 3BeHa no TeMaTHqHH HanpaBJleHHe 1, 2 H 4, KOHTO He ca nojlyqujlh Heooxo.z::.HMOTO MH03HHCTBO UpH n'bpboto rjlacybahe. 3. Pa3HH. Ilo nbpba T04Ka OT AHeBH~R pea npeac.yl1.-kop. CTecpaH BOAeHHyapOB: no stopa TOYKa OT AHeBHHJI pea 2.1. no TeMaTMYHO HanpaBl1eHHe 1 "V1HcpopMa4HoHHH H KOMYHHKa4HoHHH HayKH H TexHol1orHH" AaBaM AYMaTa Ha npeactab~teilr Ha KOM~c~sna CT.H.C. H~KoIla~ KfOpK4~eB. CT.H.C. HHKol1alil KK>pKYHes: npeo6pa3yba V1HCT~TYT no napaileilha o6pa60tka Ha ~HcpopMa~~RTa c Me>KAYHapoAHa o~ehka (B/A/A) ~ npenopbk~ - pa3w~prbahe Ha TeMaT~KaTa B nobe4e V1KT 06IlacT~, nopaa~ AOKa3aH~Te C~ npocpec~ohailh~ ycnex~, a OTAeIl~Te, KO~TO CPYHK~~oH~paT KaTO AOCTaB4~~~ Ha ycilyr~ Aa ce oprah~3~pat no Ha4~H, pa3il~4eh OT ~3CIleAOBaTeIlCKO 3BeHO; V1HCT~TYTa no ~HcpopMa~~oHH~ TeXHOIlor~~ c Me>KAYHapoAHa o~ehka (C/B/B) ~ npenopbk~ - Il~nca (cb3aabahe) Ha Kp~T~4Ha Maca B OCHOBH~Te 06naCT~ Ha V1KT, norbbkaba, A~HaM~4Ha ~ ~HTepA~c~~nIl~HapHa oprah~3a~~r Ha cek~~~te ~ V1HcT~TYTa no KOMnfOTbPH~ ~ KOMYH~Ka~~OHH~ C~CTeM~ c Me>KAYHapOAHa o~ehka (C/C/C) ~ npenopbk~ - He06xOA~MOCT OT pectpyktyp~pahe ~ ~3cIleAoBaTencKa nporpama, KOOPA~H~paHa c no-c~flh~ ~HCTV'lTYT~ B 06naCTTa, 4pe3 cn~bahe ~ Cb3AaBaHe KaTO TexeH yh~bepcaileh npabonp~emh~k CH3 V1HCTHTYT no HHcpopMa4HOHHM H KOMYHHKa4HOHHH TeXH0110rHH. npe.gmetbt Ha.geIilHOCT Ha V1HCTHTYTa no HHcb0pMaUHOHHH H KOMYHHKaYHOHHH TeXH0110rHH e: MHCHJI YHAaMeHTaIlH~ ~ np~no)f{h~ ~3cneABaH~R B 06Ilacn a Ha KOMnfOTbPH~Te HaYK~, ~HcpopMa~~OHH~Te ~ KOMYH~Ka~~OHH~Te TeXHonor~~. Pa3pa60TKa Ha ~HOBaT~BH~ ~HTepA~c~~nIl~HapH~ np~no)f{eh~r Ha ~HcpopMa~~OHH~Te ~ KOMYH~Ka~L.10HH~ TeXHOIlor~~. 1

3 npmopmten,: Pa3BVlTVle VI ynpabnehvle Ha HaL\VlOHanHVlTe enektpohhvi VlHcppaCTpYKTYPVl; CynepKOMnlOTbPHVI VI rpvla npvlno)!(ehvlfi B ekonorvlsna, MeAVlL\VlHaTa VI I8V1COKVlTe TeXHOnOrVlVl; 6eAcTBVlfI. B3eMaHe Ha pewehvlfi npvl PVlCK VI pahho npeaynpe>k, :lehvle npvl npvlpoahvi ~HTem.,reHTHVI KOMYHVlKaL\VlOHHVI CVlCTeMVI VI ycnyrvl; Web-6a3V1paHVI TeXHOnOrVlVl VI ycnyrvl; 6e3)!(Vl4HVI KOMYHVlKaL\VlVI. CeH30pHVI Mpe)!(VI VI npvlno)!(ehvlfi; napanenhvi MeTOAVI VI anropvltmvi 3a Vl34V1CnVlTenHVI 3aAa4V1 C romlma pa3mephoct VI BVlCOKa Vl34V1CnVlTenHa CnO)!(HOCT; OTKpVlBaHe, OL\eHKa VI o6pa6otka Ha CVlrHanVl; Pa3n03HaBaHe Ha 06pa3V1 VI 6V10MeTpVl4Ha VlAeHTVlcpVlKaL\Vlfl; 06pa6oTKa He VlHcpopMaL\VlfI B ceh30pha cpeaa; CeMaHTVl4HVI VI e3v1kobvi TeXHonorVlVl; BrpaAeHVI VlHTenVlreHTHVI YCTpOVlCTBa VI TeXHonorVlVl; MOAenVlpaHe VI OnTVlMVl3aL\VlfI B AVlHaMVl4HVI, VlHcpopMaL\VlOHHVI VI VlepapXVl4HVI Mpe)!(VI VI KOMnlOTbpHVI CVlCTeMVI; TeXHonorVlVl 3a o6pa6otka VI ynpabnehvle Ha 3HaHVlfI; TeXHonorVlVl 3a AVlCKpeTHa, HenpeKbCHaTa VI MHorOKpVlTepVlanHa ontvlmvl3al\vlfl VI B3eMaHe Ha pewehvlfi npvl HeonpeAeneHOCT; TeXHonorVlVl 3a nepcohanvl3v1paho 06Y4eHVle; npeac. lil1.-kop. CTecpaH BOAeHMlIapOB: '~MaMe npeano)!(ehvle Ha XaA)!(VlTOAOPOB 3a npernacybahe. noanaram OTH0180 Ha rnacybahe npeaflo)!(ehvleto Ha KOMVlCVlflTa Ha 06L40TO cb6pahvle. KOVITO noakpenfl npeaflo)!(ehvleto Ha KOMVlCVlflTa: npe06pa3yba LIIHCTMma no napal1el1ha 06pa60TKa Ha MHWopMaYMHTa, LIIHCTMTYTa no MHWopMaYMOHHM TeXH0l10rMM M LIIHcTMryTa no KOMntOTbPHM MKOMYHMKaYMOHHM CMCTeMM, lipe3 CI1MBaHe M Cb3AaBa, KaTO TexeH YHMBepCal1eH npabonpm.e~mj-imk, LIIHCTMryT no MHcb0pMaYMOHHM i.1 KOMYHMKaYMOHHM Textl0l10rMM, CbCCeAal1MllIe COcb MH 111_3, Yll. "akaa. r.60hlieb" M C npeamet Ha AeMHocT, nocolleh no-rope, MOI1H Aa rnacyba. I np. - 23; II np. - 46; 06L4o,,3a" 69. KonerVl, KOVITO ca npotvlb, Monfl Aa rnacybat. I np. - 7; IIllp. - 8; 06L4o "npotvlb" 15. KonerVl, KOVITO ce Bb3Abp)!(aT? I np. - 7; II np. - 14; 06L4o "Bb3Abp)!(anVl ce" 21. C 69 maca "Ja" npeall0>kehmeto ce npmema. ITo TpeTa TO'1Ka OT.n;HeBHIUI pe.n;... eh1i14apob/ 2

4 IfHCTUTYT no HHt/JOPM. TEXHOROfl1U - tini CO<b.l.f~ Ao A PilpeKTopa Ha JAl{/V... ;(~.~ YBa>t<aeMPil rocnoal-th/rocno>t<o APilpeKTOp, npl-1no)l{eho BL npall..\aM npe nl-1c-l-13bne4ehl-1e OT 36-TO 3aCeAaHL-1e Ha V-TO OC Ha 5AH, npobeaeho Ha 20 Mail! 2010 r., 3a BnL-13a He B cli1na Ha pewehl-1sna Ha OC Ha 5AH no npeyctpoil!ctboto Ha camoctosnenhl-1te HaY4HL-1 3BeHa Ha 5AH.

5 6bnrAPCKA AKA.QEMlllrl HA HAYKLtlTE 06LUO Cb6PAHLIIE Ha 20 MaH 2010 r. OT aca ce npobeae TpHAeceT H wectoto 3aceAaH~e Ha netoto 06l.L.\0 cb6pah~e Ha obnrapckata akaaem~s:t Ha HaYK~Te, CB~KaHO Ha OCHOBaH~e 3 OT npexoah~te ~ 3aKIlI04~TenH~Te pa3110pea6~ 1-1 B ~3nbnHeH~e Ha 4n. 5 OT 3aKoHa 3a oah. 1. II1HcpopMal.\~s:t OT npeaceaatens:t Ha obnrapckata akaaem~s:t Ha HaYK~Te akaa. Cb60T~HOB 3a pa3robop~te, Km1TO 6s:txa npobeaeh~ B4epa; 2. II1HcpopMal.\~s:t OT rnabhi-1s:t HaY4eH cekpetap 3a Cpel.L.\aTa, KOs:tTO ce e CbCTos:tna B HapoAHoTO cb6pah~e CKOMI-1CI-1s:tTa 3a HaYKa ~ 06pa30BaH~e ; 3. Pa3H~. no nbpba T04Ka OT AHeBH~s:t pea no BTopa T04Ka OT AHeBH~s:t pea no TpeTa T04Ka OT AHeBH~s:t pea: I1peAC. "tfl.-kop. CTecpaH BOAeHH"tapoB: Koner~, cnea npobeaehata AI-1CKYC~s:t no HanpaBeHI-1Te npeano>kehi-1s:t, MO>Ke 61-1 e pa3ymho Aa npeano)ka Ha BaweTO BH~MaHl-1e Aa rnacybame AaTaTa 3a 3ano"tBaHe Ha pe<j>opmata Aa 6bAe r., nopaai-1 KoeTO npeanaram Aa npl-1ctbnl-1m KbM rnacybahe Ha cneahoto: PeweHHHTa Ha OC Ha 6AH (npheth Ha 26-TO 3aceAaHHe OT r., 27-MO 3aceAaHHe OT r., 28-TO 3aceAaHHe OT r., 31-TO 3aceAaHHe OT r. H 38-TO 3aceAaHHe OT r.) no npeyctpohctboto Ha camoctohteflhhte HaY"tHH 3BeHa, "tpe3 BflHBaHe, cflhbahe, npehmehybahe H TpaHc<j>opMHpaHe OT noctohhhh HaY"tHH 3BeHa B akaaemh"thh cne4haflh3hpahh 3BeHa, BflH3aT B CHlla Ha r. MHoro Mons:t, KOVITO noakpens:t TOBa pewehl-1e, Mons:t Aa rnacyba ~ Aa ce 6po~. I np. - 32; II np. - 52; 06l.L.\0,,3a" 84. Koner~, KOI-1TO ca npoti-1b? 2 "npot~b ". Konerl-1, KOI-1TO ce Bb3Abp>KaT? 7 "Bb3Abp>Kanl-1 ce". CT.H.C. HHKOflaH MHfloweB: KOflerH, C 84 rflaca "3a", 2 "npothb" H 7 "Bb3Abp>KaflH ce", ce nphema npeaflo>kehheto pewehhhta 3a npectpyktyphpahe Aa Bfle3HaT B CHfla Ha 1-BH K)flH 2010 r. c-,j l"tfl.-kop. CT.B AeHH"tapoBI, I 1

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha IIPOTOKOJI.N!! 1 OT 3ace.n;amrn Ha KOMHc1u1Ta, Ha3HaqeHa enc 3aIToBe.n; NQ P,[(-04- l 68/24.08.20l5r. Ha A.n;MHHHCTpaTHBHH51 pokobo.[(hteji - okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha ITpoKypaTypa Pyce, 3a co6hpahe,

More information

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI:

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI: AO npeaceaa TEJl.R HA BbPXOBHM.R KACAI.lMOHEH CbA fp.cocpm.r, 6Yn.,BMTOWA" N22 TEXHM4ECKO npeano>kehme 3a npo&~~ypa 3a M36op Ha M3nbiiHMTen Ha o6lqecr8eha nop'b'fka 1.1pe3 ny6nm'iha nokaha, no ~ Ha rnaaa

More information

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA PETIYliJIHKA li'bjir APH.SI MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe OEJIACTHA )J)1PEKlJ)15I "3EME,UEJII1E" - OEmI1HCKA CJIY}KEA ITO 3EME,UEJII1E - IIJIEBEH IIJIEBEH 5800,rp.n.neaeH, y.n. "BaCV1.n neackv1"

More information

npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA "C!>OHA 3A HEABI!1>t<lr1MI!11!1MOTI-1 6bJlfAPI-1R" AACI!11..

npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA C!>OHA 3A HEABI!1>t<lr1MI!11!1MOTI-1 6bJlfAPI-1R AACI!11.. I npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA "C!>OHA 3A HEABI!1>tLilfl

More information

b ~ II H A K A 3 A H ]I b K

b ~ II H A K A 3 A H ]I b K " a." _. (~) 1:11 to~1 Llt ~,r i.i

More information

Declaration of conformity Adapter

Declaration of conformity Adapter Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 34466 Editing status: 2017-05-19 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.

More information

MHHHCTePCTBO Ha 3eMeJJ;eJIHeTO H XpaHHTe. OJiJIACTHA,n;:HPEKI(l:UI "3EME,lJ;EJIHE" - IIJIEBEH. CllIlC1>K

MHHHCTePCTBO Ha 3eMeJJ;eJIHeTO H XpaHHTe. OJiJIACTHA,n;:HPEKI(l:UI 3EME,lJ;EJIHE - IIJIEBEH. CllIlC1>K E _f'_ P1U MHHHCTePCTBO Ha 3eMeJJ;eJHeTO H XpaHHTe OJiJACTHA,n;:HPEK(l:U "3EME,lJ;EJHE" - JEBEH ClllC1>K Ha.ll.0nYCHaTHTe H He.ll.OnYCHaTHTe KaH.ll.H.ll.aTH ;::J;O yqactue B KOHKYPCa, 06RBeU C'bC 3arrOBe;::J;

More information

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Digital Archive International History Declassified digitalarchive.wilsoncenter.org November 09, 1982 Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Communist

More information

Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK" EOO,ll;-CTapfl 3aropa

Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK EOO,ll;-CTapfl 3aropa EilYliJIHKA JibJirAPH.SI O 6 JI a c T e u 1 y n p a s u T e JI u a o 6 JI a c T C T a p a 3 a r o p a Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK" EOO,ll;-CTapfl

More information

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11 .../'-,,.@3"'""'"..,o?, " -. \ -~_"''"".. { =ccl,' "- J/ ~ \ ~;l o_,.o~..,.11"11 MHOrOTIPOMJIHA 60JIHIIll,A 3A AKTHBHO JIEYEHHE " CBET A TIETKA " A.l( rp. B11)1;11H 3700, YJI. "ll,ap Cl1MEOH BEJIHKII"

More information

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9 Comparative effectiveness and safety of non-vitamin K antagonists oral anticoagulants (OACs) and warfarin in daily clinical practice: A propensity weighted nationwide cohort study. Supplementary material

More information

(12) Patent Application Publication (10) Pub. No.: US 2008/ A1

(12) Patent Application Publication (10) Pub. No.: US 2008/ A1 (19) United States US 2008.0075684A1 (12) Patent Application Publication (10) Pub. No.: US 2008/0075684 A1 Barget al. (43) Pub. Date: Mar. 27, 2008 (54) KERATIN-BINDING POLYPEPTIDES (30) Foreign Application

More information

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \.

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \. ,rep @trptw@,wffiat a ehepettnme xapakmepcmk Ha cepada e ekcnnoamaqf, 363COoB4 br &H do.' 2.9.218r. crpar4e c n3ko Ao HynAro ioj- norpnhe na HprHn tr tr no xadacmp Beedeae Xrnlex 6nox 125, x.x Apyx6a-1,rp.

More information

~-:-:'9~.~.~~~.\c?,~.,Q.:;-: r -H HHKOJIAll 3JIATAHOB HPE):(CE)l,ATEJI HA Oli~I1HCKI1CbBET KA3AHJI'bK .;'~... 9.~; L

~-:-:'9~.~.~~~.\c?,~.,Q.:;-: r -H HHKOJIAll 3JIATAHOB HPE):(CE)l,ATEJI HA Oli~I1HCKI1CbBET KA3AHJI'bK .;'~... 9.~; L PETIYEAMKAnbArAPM~ 06JIaCTHa a,li:mhhhctparuu1 CTapa 3aropa N!! 06-00-791.;'~... 9.~;.. 2012 L ):(0 r-h TIJIAMEH TIETPYHOB TIPE)l,CE)l,ATEJI HA AJ~MMHMCTPATMBEHCl~JI. rp. CTAPA 3ArOPA KOTIIIE: l~o r -H

More information

NOTICE TO MEMBERS No May 10, 2006

NOTICE TO MEMBERS No May 10, 2006 NOTICE TO MEMBERS No. 2006 061 May 10, 2006 SYMBOL CONVERSION LONG-TERM EQUITY OPTIONS EXPIRING IN JANUARY 2007 Bourse de Montréal Inc. (the Bourse) and (CDCC) hereby inform all option participants that

More information

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /v IIA P() Br.No II(} CIII;tr'AII[IE nu u Ao -- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v T.XA IIEIIKA IIATIEBA Y ybaxaema rociioxo IPEACEAATEJT, Ha ocnosahre qjr. 8'1, a* 1 or Koscrvryr\uflTa

More information

A Sound Track to Reading

A Sound Track to Reading A Sound Track to Reading Blending Flashcards Prepared by Donald L Potter June 1, 2018 Mr. Potter prepared these cards to be used with Sister Monica Foltzer s advanced intensive phonics program and reader,

More information

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Neil Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter White, Andrew Lloyd, Fabio Luciani on behalf of

More information

Karen Sakala, RN BSN, PCMH-CCE Diabetes Advisory Council June 20, 2014

Karen Sakala, RN BSN, PCMH-CCE Diabetes Advisory Council June 20, 2014 Karen Sakala, RN BSN, PCMH-CCE Diabetes Advisory Council June 20, 2014 ! Focused on Community Health Centers (FQHCs) in NM! Goal: To improve the ABCs of diabetes! FY 2009-10: Assessment questionnaire!

More information

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c.

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c. )(europoss Asro6xorpaolae Co6creexo lme. flpe3xme. OaMr4nus nhqfla,4l-loopt Al-]t4fl t4dea [4nageloBa Q 6tnrapm, UJyueH - 9700,. E A E:AaI: non xefia laara Ha pamahe, '1985 I Hal{uohanHocr 6bnrapi,{i no3

More information

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP"_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt BoJnfrsoJrEH K4yE,,MLr OP"_fP.tEPH[K 060/ r ttl- $ t).',0- W /ao TPEACEAATEJU HA OETTWCKVTCbB fp. [E,PH4K AOKJAAHA 3ATCKA Or YC ua BK,,MuHrop" - flepuzr OTHOCHO: flocransse Ha pekrlama YBA}KAEMA OCOAH

More information

ABTOEhOfPAOt'1f. r Pyceea ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha

ABTOEhOfPAOt'1f. r Pyceea ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha ABTOEhOfPAOt'1f HA Henn r Pyceea aapec: rp.tljyuex, Po,qeHa cbm Ha 11 ro\nau. 1966 ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha B ttouexra pa6orn a llly,,enncxon KoscraxrrH [lpecnaacrn"' Karo frlabeh

More information

IN PREVIOUS PAPERS 8 9

IN PREVIOUS PAPERS 8 9 Diminished Response of the Circulating Eosinophils to Adrenalin in Azoospermic and Oligospermic Patients J. Landau, M.D., B. Eckerling, M.D., and S. Feldman, M.D. IN PREVIOUS PAPERS 8 9 impairment of dark-adaptation

More information

!"#$%&" '($&)*+,"-.(/%*+,"

!#$%& '($&)*+,-.(/%*+, !"#$%&" '($&)*+,"-.(/%*+," 01%/2),3"4).5"61%7$28"6%9)$5"%$"#/2++7! The Healthy Schools Partnership: Innovative Energy Balance Programming with RD Nutrition Coaches :%871"6%815;"

More information

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME ,11;0 OEIJ:J;OTO C'bEPAH:UE HA C'b,[QI:UTE OT HAKA3ATEJIHATA KOJIErJiUI HA B'hPXOBHIDI KACAI(IIOHEH Cp)]; H C K A H E OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO

More information

.00. TEXHII14ECKO npe,llflo>kehliie

.00. TEXHII14ECKO npe,llflo>kehliie .00 np1lo>keh1e N2 2 06pa3eu "C5A103 - COll1fl 05flACT" EOO,ll rp.cocp111~, 6yn."CToneToB" N2 67 TEXH14ECKO npe,llflo>kehliie 38 Y48CT!t18 8 OTKpLt1T8 npou,8ayp8 38 8b3n8r8He H8 06lJ..8CT88H8 nopb4k8

More information

COMPLETE DOMINANCE. Autosomal Dominant Inheritance Autosomal Recessive Inheritance

COMPLETE DOMINANCE. Autosomal Dominant Inheritance Autosomal Recessive Inheritance COMPLETE DOMINANCE In complete dominance, the effect of one allele completely masks the effect of the other. The allele that masks the other is called dominant, and the allele that is masked is called

More information

Test Results Standard. Appearance Light yellow, fine powder Matches std. Odour Characteristic Matches std. Taste Characteristic Matches std

Test Results Standard. Appearance Light yellow, fine powder Matches std. Odour Characteristic Matches std. Taste Characteristic Matches std PEA PROTEIN POWDER (Pisum sativum) Product: certified pea protein powder - bulk Lot code of supplier: BL 010-14 Date of production: 10-04-2017 (BBD: 10-04-2019) Date of analysis: 10-04-2017 Appearance

More information

*,{ /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly. r-xa TIBETA KAPA.flHTTEBA 6t. ybaikaema rociiox(o ITPEACEAATEJT,

*,{ /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly. r-xa TIBETA KAPA.flHTTEBA 6t. ybaikaema rociiox(o ITPEACEAATEJT, /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly *,{ r-xa TIBETA KAPA.flHTTEBA 6t ybaikaema rociiox(o ITPEACEAATEJT, Ha ourosauu,e ul. 87, ar. 1 or Koncruryr\trflTa ua Peuy6Jrr{Ka

More information

GCIG updates PORTEC-3 and PORTEC-4a

GCIG updates PORTEC-3 and PORTEC-4a GCIG updates PORTEC-3 and PORTEC-4a Lisbon, October 2016 Carien Creutzberg Leiden University Medical Centre, The Netherlands The PORTEC-3 trial High risk Endometrial Cancer R Pelvic RT (48.6 Gy) 686 Pelvic

More information

KOIlEKTIf1BEH TPY.QOB.QOrOBOP. TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET

KOIlEKTIf1BEH TPY.QOB.QOrOBOP. TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET KOIlEKTIf1BEH TPY.QOB.QOrOBOP HA TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET - COCDIf1f1 AHec, 18.03.2015 r., B rpaa COCPI!151Me>K,D,Y:PbKOBO,o,CTBOTO Ha TY - COCPI!151, npe,o,ctabn51baho OT pexropa nporp,,o,th

More information

Uniquely Human A Different Way to See Autism and Create Pathways to Success

Uniquely Human A Different Way to See Autism and Create Pathways to Success !"#$"#$ Special Agents of Change Spring 2015 Webinar Series Uniquely Human: A Different Way to See Autism and Create Pathways to Success Presenter: Barry M. Prizant, Ph.D., Childhood Communication Services

More information

Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty?

Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty? Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty? * 1,2 ATSUSHI SATO, MD, PhD, * 1,2 Takayuki Koya, * 2,3 Hiroshi Takagi, * 2 Jun Oike,, * 2 Saki Yagura, * 2

More information

Quality of Life after. A Critical Illness: A review of the literature

Quality of Life after. A Critical Illness: A review of the literature 1 Quality of Life after A Critical Illness: A review of the literature 1998 2003 by Harriet Adamson BN MAdEd A Thesis submitted in fulfillment of the requirements for the degree Master of Nursing (Honours)

More information

KOHL\Enl\"1R. 3A YnPABJ1EH"1E HA C"1CTEMATA "1 npo~eca HA fpaacko n11ah"1pahe..., fpaaoyctpolllctbehoto PA3B"1T"1E HA CTOJ1"14HA 06UJ.

KOHL\Enl\1R. 3A YnPABJ1EH1E HA C1CTEMATA 1 npo~eca HA fpaacko n11ah1pahe..., fpaaoyctpolllctbehoto PA3B1T1E HA CTOJ114HA 06UJ. KOHL\Enl\"1R 3A YnPABJ1EH"1E HA C"1CTEMATA "1 npo~eca HA fpaacko n11ah"1pahe..., fpaaoyctpolllctbehoto PA3B"1T"1E HA CTOJ1"14HA 06UJ."1 HA -.... -- -.. l.'bbbeaeh"1e B CbOTBeTCTBllle c ynpabjlehckara nporpama

More information

Aspirin as Venous Thromboprophylaxis

Aspirin as Venous Thromboprophylaxis Canadian Society of Internal Medicine Nov 2, 2017 Aspirin as Venous Thromboprophylaxis Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto Disclosures

More information

Mass Spectrometry Course Árpád Somogyi Chemistry and Biochemistry MassSpectrometry Facility) University of Debrecen, April 12-23, 2010

Mass Spectrometry Course Árpád Somogyi Chemistry and Biochemistry MassSpectrometry Facility) University of Debrecen, April 12-23, 2010 Mass Spectrometry Course Árpád Somogyi Chemistry and Biochemistry MassSpectrometry Facility) University of Debrecen, April 12-23, 2010 Introduction, Ionization Methods Mass Analyzers, Ion Activation Methods

More information

Partitioning genetic variance of metabolizable energy efficiency in dairy cows

Partitioning genetic variance of metabolizable energy efficiency in dairy cows Partitioning genetic variance of metabolizable energy efficiency in dairy cows Mehtiö, T., Negussie, E., Mäntysaari, P., Mäntysaari, E.A., Lidauer, M.H.* Natural Resources Institute Finland (Luke) EAAP

More information

DOWNLOAD OR READ : WHAT YOYR DR NOT TELL BREAST CANCER PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : WHAT YOYR DR NOT TELL BREAST CANCER PDF EBOOK EPUB MOBI DOWNLOAD OR READ : WHAT YOYR DR NOT TELL BREAST CANCER PDF EBOOK EPUB MOBI Page 1 Page 2 what yoyr dr not tell breast cancer what yoyr dr not pdf what yoyr dr not tell breast cancer Today, it has been

More information

mpb6onposoaha apmamypa, peci>.n

mpb6onposoaha apmamypa, peci>.n npotokojl or Ae~Hocna Ha KOMI'ICI'IR, Ha3Ha4eHa c PeweHI'Ie N2 420/27.12.16 r. 3a pa3rne>+

More information

ischemic stroke, transient ischemic attack, or peripheral artery embolism

ischemic stroke, transient ischemic attack, or peripheral artery embolism Appendix Table S1: ICD- 8/1 codes and ATC- codes Population Acute myocardial infarction Defined from primary inpatient diagnoses codes PCI Defined from procedure codes Non- valvular atrial fibrillation

More information

Japanese Deep Vein Thrombosis

Japanese Deep Vein Thrombosis Japanese Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Artificial joint and cartilage implantation center, Kitasato institute hospital, Kitasato university Yasunori Tsukimura

More information

Chem 4B Spring 2018 Exam 3

Chem 4B Spring 2018 Exam 3 Chem 4B Spring 2018 Exam 3 TOTAL PONTS 80 / 100 QUESTON 1 Hydrocarbon 12 pts 1.1 name and circle stereocenters 2 / 6 + 0 pts Correct cis-6-methyl-5-propylnon-3-ene + 1 pts 6-methyl + 1 pts 5-propyl + 0.5

More information

Theme song for the 2018 Los Angeles Religious Education Congress Rise Up! Levántate! A/E. j œ. œ œ. Œ œ œ. Dios te. œ œ œ œ

Theme song for the 2018 Los Angeles Religious Education Congress Rise Up! Levántate! A/E. j œ. œ œ. Œ œ œ. Dios te. œ œ œ œ Theme sog for the 2018 Los Ageles Religious ducatio Cogress Up! vátate! ditio 0140629 Based o zekiel 7:1214; Romas 8:8 11; oh 11:1 45 stela GarcíaLópez ad Rodolfo López & & & & & & INTRO (q = ca 124) (o)

More information

Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Terapia ormonale: quando e a chi?

Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Terapia ormonale: quando e a chi? Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Terapia ormonale: quando e a chi? Paolo Andrea Zucali Dipartimento di Oncologia HUMANITAS CANCER CENTER Rozzano - Milano AGENDA Literature

More information

Real World Evidence in the Treatment of Ovarian Cancer. Elizabeth Eisenhauer MD FRCPC Queen s University

Real World Evidence in the Treatment of Ovarian Cancer. Elizabeth Eisenhauer MD FRCPC Queen s University Real World Evidence in the Treatment of Ovarian Cancer Elizabeth Eisenhauer MD FRCPC Queen s University Outline What is real world evidence (RWE) and how can it shape policy and practice? In ovarian cancer,

More information

Status of anticoagulation therapy in 2016: Is there a need for venous revascularization?

Status of anticoagulation therapy in 2016: Is there a need for venous revascularization? Status of anticoagulation therapy in 2016: Is there a need for venous revascularization? Rupert M. Bauersachs Dept. of Vascular Medicine, Darmstadt Center of Thrombosis Hemostasis, Mainz Status of anticoagulation

More information

OlillJ;HHA KA3AHJIb~ AOKl1AA. ,qo

OlillJ;HHA KA3AHJIb~ AOKl1AA. ,qo \ OlllJ;HHA KA3AHJb~,qO 06l~HCK~ CbBET - KA3AHflbK AOKlAA no lfn. 93 OT npabmnhmka 3a oprahm3a4mrta MAeMHocTTa 06~MHCKoR C"bBeT OT ranmha reoprmeba CToRHoBa KMeT Ha 06~MH Ka3aHn"bK OTHOCHO: npo,qa>k6a

More information

Moving on - the next step in developing an International Classification System for Cancer Pain

Moving on - the next step in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk, Pablo Amigo, Amanda Brisebois, Sarah Burton Macleod, Rebekah Gilbert, Yoko Tarumi, Vincent Thai, Gary Wolch, Lara Fainsinger & Viki Muller Division of Palliative Care

More information

,\BTOEHOTPAOH.fl. fi.irrxhocr: llne: Eoxr.rlapr? lo nunhurejrha r.ruqopruaunn: llor: xeha. HaunoHarHocr: Eurapxa

,\BTOEHOTPAOH.fl. fi.irrxhocr: llne: Eoxr.rlapr? lo nunhurejrha r.ruqopruaunn: llor: xeha. HaunoHarHocr: Eurapxa ,\BTOEHOTPAOH.fl llne: Eoxr.rlapr?, C'ro.sHoea Aapec: Ernrapur:, Te.neQoH: E-mail: HaunoHarHocr: Eurapxa fl.ara Ha par(aaue: 1955 r. lo nunhurejrha r.ruqopruaunn: llor: xeha Cemeftso rrojroxehue: ombxeha

More information

Clinical History. CHD-PAH Case: Physical Exam. Clinical History. To Repair or not to Repair?

Clinical History. CHD-PAH Case: Physical Exam. Clinical History. To Repair or not to Repair? CHD-PAH Case: To Repair or not to Repair? Erika Berman Rosenzweig, MD Columbia University, College of Physicians and Surgeons Clinical History 18 year old female had been previously well, but new murmur

More information

KA3AHJI'LK. ,l(okjia,l(

KA3AHJI'LK. ,l(okjia,l( KA3AHJI'LK,L(O r -H HHKOJIA:fi 3JIATAHOB IIPE,L(CE,L(ATEJI HA OJ>Il(HHCKH C'bBET - KA3AHJl'bK 0611lHHCKH C'LBET KOA3AHA'hK N9 C- '01.f ~ Ay.o9. 2o~r.,l(OKJIA,l( no '{JI. 93 OT IlpaBHJIHHKa 33 oprahh33d;uhta

More information

eluting Stents The SPIRIT Trials

eluting Stents The SPIRIT Trials Everolimus-eluting eluting Stents The SPIRIT Trials Gregg W. Stone, MD Columbia University Medical Center Cardiovascular Research Foundation Abbott XIENCE V Everolimus-eluting eluting Stent Everolimus

More information

Courses in the Bachelor program in Psychology (major)

Courses in the Bachelor program in Psychology (major) Universität Zürich Binzmühlestrasse 1, Box 1 CH-8050 Zürich www.psychologie.uzh.ch Fall Semester 2016 Clinical Psychology 200a00x 00x Angststörungen Theorien, Befunde und Therapiemöglichkeiten (Anxiety

More information

PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES

PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY CANCER PATIENTS: CURRENT GUIDELINES Mario Mandalà, MD Unit of Clinical Research Department of Oncology and Haematology Papa Giovanni XXIII Hospital Cancer Center

More information

Preservation methods for fish oil

Preservation methods for fish oil Preservation methods for fish oil Charlotte Jacobsen Professor and group leader Research group for Bioactives Analysis and Application chja@food.dtu.dk Agenda Intro to antioxidants Different examples on

More information

ASSESSMENT OF EFFECTIVENESS

ASSESSMENT OF EFFECTIVENESS W.M. Glinkowski 1,2,3,A.Górecki 1 WEB BASED DATABASE FOR THE ASSESSMENT OF EFFECTIVENESS OF THROMBOEMBOLIC PROPHYLAXIS IN ORTHOPAEDIC SURGERY. PRELIMINARY STUDY 1 Chair and Department of Orthopaedics and

More information

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. European Digestive Cancer Days, Prague - 26. September 2017 QUANTITATIVE FIT

More information

PENS 2017 Minneapolis, MN April 27, Disclosure. Objectives: Growth Hormone Guidelines Roundtable

PENS 2017 Minneapolis, MN April 27, Disclosure. Objectives: Growth Hormone Guidelines Roundtable Growth Hormone Guidelines Roundtable PENS 2017 Minneapolis, MN April 27, 2017 Panelists: Mary S. Burr, DNP, CPNP-PC Catherine P. Metzinger, AAS, RN, CDE Bradley S. Miller, MD, PhD Disclosure Dr. Miller

More information

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of

More information

1. はじめに. Key Words : Mini - Mental State Examination MMSE ; Folstein et al., Dementia Japan 27 : , 2013

1. はじめに. Key Words : Mini - Mental State Examination MMSE ; Folstein et al., Dementia Japan 27 : , 2013 360 Dementia Japan 27 : 360-366, 2013 原著 1 1 1 1 1 2 要旨 122 5 3 3 HDS - R 14.7±6.5 16.5±7.6 p

More information

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf

More information

Low Back Pain. Chronic Low Back Pain 4/19/16. Low-back pain is one of the most common painful conditions experienced by humans throughout their life.

Low Back Pain. Chronic Low Back Pain 4/19/16. Low-back pain is one of the most common painful conditions experienced by humans throughout their life. Chronic James J. Lehman, DC, MBA, FACO Associate Professor of Clinical Sciences University of Bridgeport College of Chiropractic Director of Health Sciences Postgraduate Education Department University

More information

! "##$ %&' "89 %": F,G %D: F,G %D: -! "# $ #"2, 0 .L FS "J 78! F9# +I l=- ^8# +A LF : F X!F +, +A E +! E H #; E l=- ]B # E [: > L

! ##$ %&' 89 %: F,G %D: F,G %D: -! # $ #2, 0 .L FS J 78! F9# +I l=- ^8# +A LF : F X!F +, +A E +! E H #; E l=- ]B # E [: > L -! "# $ 12-7 012 (1388 +,- (65 (19 % 1388/3/23 : 1387/3/9 : F,G %D: F,G %D: (Original Article)! "##$ %&' 4 3 4 56 0 2 #"2, 0 1.$ "*+/$ 0 () *+ ", (78! "# $ ( ( 9 (.1.78! "# $ (:;

More information

Microrint pulmonary function testing in older adults with an intellectual disability

Microrint pulmonary function testing in older adults with an intellectual disability Respiratory Medicine (2009) 103, 1954e1959 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Microrint pulmonary function testing in older adults with an intellectual disability

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

HumaTex Febrile Antigens

HumaTex Febrile Antigens Design Verification HumaTex Febrile Antigens Contents 1 Function... 2 2 Product Line... 2 3 Sensitivity... 2 Description of Control Materials... 2 Kit controls Positive and Negative... 3 4 Interferences...

More information

Operational investigation of TCAS reports by pilots

Operational investigation of TCAS reports by pilots direction générale de l Aviation civile direction des services de la Navigation aérienne Operational investigation of TCAS reports by pilots Christian Aveneau, Bernard Hasquenoph & Beatrice Raynaud 1 Content

More information

ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE.

ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE. ANALYSIS OF IL17 AND IL17RA POLYMORPHISMS IN SPANISH PSORIASIS PATIENTS: ASSOCIATION WITH RISK FOR DISEASE. Batalla A, Coto E*, González-Lara L, González- Fernández D, Maldonado-Seral C, García-García

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA 2 DS 2 -VASc score in predicting ischemic stroke, thromboembolism, and death

More information

How sarcoma/gist research & expert care are organized in Italy

How sarcoma/gist research & expert care are organized in Italy How sarcoma/gist research & expert care are organized in Italy Organization of care Historical migration for medical care PR VA LC VI TV BG LU GR PG CN AL MI Desi o LO PV Alzano Lombardo CO Casalpusterlen

More information

1. YllacmHuK "HUKOJl06 KbHCmpaKUl'bH" EOOJ(

1. YllacmHuK HUKOJl06 KbHCmpaKUl'bH EOOJ( npmjo~eume K'LM DPOTOKOJ Ha KOMHCHJ, Ha:ma'leHa C'bC anobe)], NQ P,n-l0- OT 8.0.20 r. Ha Hn'bJHHTeJHHH )],HpeKTOp Ha HaUHOHaJHa cjylk6a a C'bBeTH B eme)],ejheto (HCC)- hjolkhtej a no)]'60p Ha Y'laCTHHUHTe,

More information

Profile of Respondents Phase 1 F2F Focus Group 1

Profile of Respondents Phase 1 F2F Focus Group 1 Profile of Respondents Phase 1 F2F Focus Group 1 Name M/F Gender demographic classification Diagnosed with long term chronic healthcare Chronic healthcare minutes of physical activity a week Attitudinal

More information

SNUBBER CAPACITOR WITH AXIAL LEADS

SNUBBER CAPACITOR WITH AXIAL LEADS Tan δ x 5 4 3 2 TEMPERATURE V/S DISSIPATION FACTOR 5 55 C 25 C +25 C +55 C Temperature +75 C + C ΔC FREQUENCY V/S % CHANGE IN CAPACITANCE C %.5 Highlights, Lw lss plyprpylene dielectric, High frequency

More information

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example Main objective of Epidemiology Inference to a population Example: Treatment of hypertension: Research question (hypothesis): Is treatment A better than treatment B for patients with hypertension? Study

More information

Thin Film PV Technologies CIGS PV Technology

Thin Film PV Technologies CIGS PV Technology Thin Film PV Technologies CIGS PV Technology Week 5.3 Arno Smets CIGS NiA1 MgF 2 TCO (ZnO:Al) TCO (intrinsic ZnO) CdS (n-type) CuInSe 2 (p-type) Mo Glass CIGS IV- semiconductors: III- V semiconductors:

More information

HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism

HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism Determination of Ethylene Glycol, Propylene Glycol, Oxalic Acid and Glycolic Acid BioReliance Study Number Testing

More information

From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension

From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension Dr Rachel Davies Respiratory Physician National Pulmonary Hypertension Service Hammersmith Hospital Royal College of Physicians

More information

YBAXAEMII AAMI{ I,I TOCNOAA OEIIIUHCKI,T CbBETHI,IqII, 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322

YBAXAEMII AAMI{ I,I TOCNOAA OEIIIUHCKI,T CbBETHI,IqII, 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322 e-mai l:obs@tarsovishte.bg; www.!arcovishte.bq 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322 ot nllx. XarxAr(e AnleBa - npeaceaaren Ha O6u Hcxx clbet TlproBuue othocho: yrbt,pxrabahe

More information

Obstructive Sleep Apnea as a Risk Factor After Shoulder Arthroplasty

Obstructive Sleep Apnea as a Risk Factor After Shoulder Arthroplasty Obstructive Sleep Apnea as a Risk Factor After Shoulder Arthroplasty Justin W. Griffin, MD, Wendy M. Novicoff, PhD James A. Browne, MD Stephen F. Brockmeier, MD Department of Orthopaedic Surgery Division

More information

UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS

UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS Armando Mansilha MD, PhD, FEBVS 16 th National Congress of the Italian Society of Vascular and Endovascular Surgery Bologna, 2017 Disclosure I have the following

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Supplemental Methods Lipid extraction. Tissue was pulverized with a mortar and pestle or a ball-grinding method (Mikro Dismembrator, Sartorius). All subsequent steps were performed

More information

DCP Networks

DCP Networks www.bps.org.uk/dcp DCP Networks To support and promote clinical psychology, working collaboratively with people who use our services and wider communities to improve wellbeing and to promote the unique

More information

How to Diagnose Pulmonary Embolism anno 2014?

How to Diagnose Pulmonary Embolism anno 2014? How to Diagnose Pulmonary Embolism anno 2014? Mark H.H. Kramer, MD, PhD, FRCP FACP Professor of Medicine VU University Medical Center Amsterdam, The Netherlands What are we going to discuss? Age adjusted

More information

ECAT FOUNDATION REPORT

ECAT FOUNDATION REPORT ECAT External quality Control for Assays and Tests REPORT SURVEY 017-M Main Labcode 990715 Copyright 017 ECAT Foundation NECAT f r External quality Control for Assays and Tests Page 3 of 15 OVERVIEW Z-SCORES

More information

December 2014 MRC2.CORP.D.00011

December 2014 MRC2.CORP.D.00011 This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking

More information

Cancer Associated Thrombosis: six months and beyond. Farzana Haque Hull York Medical School

Cancer Associated Thrombosis: six months and beyond. Farzana Haque Hull York Medical School Cancer Associated Thrombosis: six months and beyond Farzana Haque Hull York Medical School Disclosure I have no disclosure The Challenge of Anticoagulation in Patients with Venous Thromboembolism and Cancer

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information

Etv4 BU EMM Etv5 BC MMM UI-M-BH3- Elk1 BC MMM

Etv4 BU EMM Etv5 BC MMM UI-M-BH3- Elk1 BC MMM Supplementary Tables In situ hybridization probes Genbank Gene Accession Number Clone ID Cat. No Etv1 BC005645 PCR Etv4 BU053662 5062538 EMM1002-5544031 Etv5 BC034680 4036564 MMM1013-7511524 Fev AI876263

More information

Mandatory Elements of Healthcare Reform Walter Coleman. healthcare consulting

Mandatory Elements of Healthcare Reform Walter Coleman. healthcare consulting Mandatory Elements of Healthcare Reform Walter Coleman 1 Agenda ACA Mandatory Elements of Reform Value Based Purchasing Readmission Reduction Program Hospital Acquired Conditions Best practices to analyze

More information

Implements or Conforms to Federal Regulation [150B-21.3A(d1)] Federal Regulation Citation

Implements or Conforms to Federal Regulation [150B-21.3A(d1)] Federal Regulation Citation G.S. 150B-21.3A Report for 10A NCAC Chapter 17, Services for the Deaf and Hard of Hearing Agency - Department of Health and Human Services Comment Period - October 13, 2016 through December 13, 2016 Date

More information

EFFECT OF IRRADIATION IN INFANCY ON THE MOUSE OVARY

EFFECT OF IRRADIATION IN INFANCY ON THE MOUSE OVARY EFFECT OF IRRADIATION IN INFANCY ON THE MOUSE OVARY A QUANTITATIVE STUDY OF OOCYTE SENSITIVITY HANNAH PETERS and EMILIA LEVY Einsen Laboratory, Copenhagen, Denmark (Received 13th June 1963) Summary. The

More information

IIII,. I~2. II ll ll 111 *2_ 11L. 1.6 MICROCOPY RESOLUTION TEST CHART NA10,NAL C'F4A SANL[ [

IIII,. I~2. II ll ll 111 *2_ 11L. 1.6 MICROCOPY RESOLUTION TEST CHART NA10,NAL C'F4A SANL[ [ A7 AA37 729 EFFECT OF PFDA'ON CARDIAC MEMBRANE FUNCTIONU) WRIOHT 1/ STATE UNIV DAYTON ON DEPT OF PHARMACOLO00 A E LANGLEY MAR 83 AFOSR-TR-84-0020 AFOSR-82-0284 UNG ASSFEU F0G6/20 NL 3-8 IIII,. I~2 II.2

More information

Courses in the Bachelor program in Psychology (major)

Courses in the Bachelor program in Psychology (major) Universität Zürich Binzmühlestrasse 1, Box 1 CH-8050 Zürich www.psychologie.uzh.ch Fall Semester 2016 Clinical Psychology 200a00x 00x Angststörungen Theorien, Befunde und Therapiemöglichkeiten (Anxiety

More information

\{ usnrrorererence. I March 1996

\{ usnrrorererence. I March 1996 \{ usnrrorererence 7 I March 1996 Trial No. DXV036 rodrxanol (vis rpaeueo) rn raediatrtc ANcrocAR-DIocRApHy An open phase II trial with iodixanol 320 mg Vml and a double-blind, parallel, randomized phase

More information

Inibitori delle chinasi ciclino dipendenti nel trattamento della malattia metastatica HR-positiva Gli studi clinici

Inibitori delle chinasi ciclino dipendenti nel trattamento della malattia metastatica HR-positiva Gli studi clinici Inibitori delle chinasi ciclino dipendenti nel trattamento della malattia metastatica HR-positiva Gli studi clinici Laura Orlando UOC Oncologia & Breast Unit Brindisi Verona 22/04/2016 Summary Studi con

More information

Supporting Information

Supporting Information Supporting Information R6G/8-AQ co-functionalized Fe 3 O 4 @SiO 2 nanoparticles for fluorescence detection of trace Hg 2+ and Zn 2+ in aqueous solution Yao Gu 1,2, Guowen Meng 1,3*, Meiling Wang 1, Qing

More information